Patents by Inventor Jörg Goldhahn

Jörg Goldhahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE DAMAGE AND ARTHRITIS
    Publication number: 20220331398
    Abstract: The invention provides methods and compositions for the treatment of cartilage damage or arthritis.
    Type: Application
    Filed: May 6, 2022
    Publication date: October 20, 2022
    Inventors: Jörg Goldhahn, Kristen Johnson, Celeste Scotti, Igor Vostiar
  • Methods and compositions for treatment of cartilage damage and arthritis
    Patent number: 11351223
    Abstract: The invention provides methods and compositions for the treatment of cartilage damage or arthritis by administration of a protease-resistant ANGPTL3 polypeptide with chondrogenic activity.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: June 7, 2022
    Assignee: Novartis AG
    Inventors: Jörg Goldhahn, Kristen Johnson, Celeste Scotti, Igor Vostiar
  • METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE DAMAGE AND ARTHRITIS
    Publication number: 20190269754
    Abstract: The invention provides methods and compositions for the treatment of cartilage damage or arthritis.
    Type: Application
    Filed: November 13, 2017
    Publication date: September 5, 2019
    Inventors: Jörg Goldhahn, Kristen Johnson, Celeste Scotti, Igor Vostiar
  • Methods of Improving or Accelerating Physical Recovery After Surgery for Hip Fracture
    Publication number: 20180230221
    Abstract: The disclosure relates to novel uses and regimens for accelerating/improving physical recovery in a patient with disuse atrophy triggered by reduced mobility due to a hip fracture and consequent major surgery, which employ a therapeutically effective amount of a myostatin antagonist, e.g., a myostatin binding molecule, e.g., a myostatin antibody or an ActRII receptor binding molecule, an ActRII receptor antibody, such as the bimagrumab antibody.
    Type: Application
    Filed: April 10, 2018
    Publication date: August 16, 2018
    Inventors: Laszlo Tanko, Dimitris PAPANICOLAOU, Jörg GOLDHAHN
  • Administration of bimagrumab for improving muscle mass and function after hip fracture surgery
    Patent number: 9969806
    Abstract: The disclosure relates to uses and regimens for accelerating/improving physical recovery in a patient with disuse atrophy triggered by reduced mobility due to a hip fracture and consequent major surgery, which employ a therapeutically effective amount of a myostatin antagonist, e.g., a myostatin binding molecule, e.g., a myostatin antibody or an ActRII receptor binding molecule, an ActRII receptor antibody, such as the bimagrumab antibody.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: May 15, 2018
    Assignee: Novartis AG
    Inventors: Laszlo Tanko, Dimitris Papanicolaou, Jörg Goldhahn
  • Methods of Improving or Accelerating Physical Recovery After Surgery for Hip Fracture
    Publication number: 20170029513
    Abstract: The disclosure relates to uses and regimens for accelerating/improving physical recovery in a patient with disuse atrophy triggered by reduced mobility due to a hip fracture and consequent major surgery, which employ a therapeutically effective amount of a myostatin antagonist, e.g., a myostatin binding molecule, e.g., a myostatin antibody or an ActRII receptor binding molecule, an ActRII receptor antibody, such as the bimagrumab antibody.
    Type: Application
    Filed: April 24, 2015
    Publication date: February 2, 2017
    Applicant: Novartis AG
    Inventors: Laszlo Tanko, Dimitris PAPANICOLAOU, Jörg GOLDHAHN
  • Device for fixing implants on or in a bone
    Patent number: 6645212
    Abstract: The present invention concerns a fastening element for use in bone, and in particular to a device for fixating implants on or in bone. The device may have a longitudinal axis for anchoring in bone and may comprise a core and at least one wing extending from the core. The wing may have an enlarged peripheral portion adapted to contact bone. A cross-section of the device transverse to the longitudinal axis may have first and second portions, the first portion comprising the core and defining a first cross-sectional area, the second portion comprising the enlarged peripheral portion of the at least one wing and defining a second cross-sectional area, and the second cross-sectional area preferably is greater than the first cross-sectional area.
    Type: Grant
    Filed: October 18, 2002
    Date of Patent: November 11, 2003
    Assignee: Synthes (U.S.A.)
    Inventors: Jörg Goldhahn, Reto Frei, Jörn Seebeck